Alastair MacLennan
Adelaide Medical School
Faculty of Health and Medical Sciences
Emeritus Professor Alastair MacLennan, AO, MB ChB, MD, FRCOG, FRANZCOG is Head of the Australian Collaborative Cerebral Palsy Research Group at the Robinson Research Institute, The University of Adelaide. His research group specifically studies causation and the genetic pathways to cerebral palsy. He was the third Professorial Head of Obstetrics and Gynaecology. He is also Vice President of Friends of Science in Medicine.
Research Interests
My main research interests are now in the causes of cerebral palsy and in particular the genetic and epigenetic causes.
i also continue my interest in having a quality evidence base for all health interventions both traditional and alternative. Alternative therapies currently are poorly regulated, often have associated unproven claims for safety and efficacy and are often driven by the vested interests of industry.
-
Appointments
Date Position Institution name 2012 - ongoing Emeritus Professor The Robinson Resaerch Institute 2012 - ongoing Honorary Vice President Friends Of Science in Medicine 2006 - 2012 Professor and Head of the Discipline of Obstetrics and Gynaecology University of Adelaide, Adelaide -
Awards and Achievements
Date Type Title Institution Name Country Amount 2011 Award Professor Derek Frewin Excellence in student teaching Award The University of Adelaide - - 2011 Honour Officer in the Order of Australia (AO) Australian Government Australia - 2009 Award South Australian Government’s Science Excellence Award for Public Good. South Australian Government Australia 10,000 -
Education
Date Institution name Country Title University of Glasgow, RCOG London, RANZCOG Melbourne United Kingdom OA, MB ChB, MD, FRCOG, FRANZCOG -
Postgraduate Training
Date Title Institution Country Glasgow, Chicago, Oxford, San Fransisco, Adelaide Universities of the above Scotland, USA, England and Australia -
Research Interests
-
Journals
Year Citation 2024 Sandran, N. G., Fornarino, D. L., Corbett, M. A., Kroes, T., Gardner, A. E., MacLennan, A. H., . . . van Eyk, C. L. (2024). Application of multiple mosaic callers improves post-zygotic mutation detection from exome sequencing data. Genetics in Medicine, 26(10), 101220-1-101220-14.
2024 Wang, Y., Xu, Y., Zhou, C., Cheng, Y., Qiao, N., Shang, Q., . . . Xing, Q. (2024). Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy. Nature Medicine, 30(5), 1395-1405.
Scopus4 Europe PMC12023 van Eyk, C., MacLennan, S. C., & MacLennan, A. H. (2023). All Patients With a Cerebral Palsy Diagnosis Merit Genomic Sequencing. JAMA Pediatrics, 177(5), 455-456.
Scopus8 WoS3 Europe PMC32022 Kayumi, S., Pérez-Jurado, L. A., Palomares, M., Rangu, S., Sheppard, S. E., Chung, W. K., . . . Corbett, M. A. (2022). Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants. Genetics in Medicine, 24(11), 2351-2366.
Scopus23 WoS4 Europe PMC122022 Martin, M., Hill, C., Bewley, S., MacLennan, A. H., & Braillon, A. (2022). Transgenerational adverse effects of valproate? A patient report from 90 affected families. Birth Defects Research, 114(1), 13-16.
Scopus21 Europe PMC52021 van Eyk, C. L., Webber, D. L., Minoche, A. E., Pérez-Jurado, L. A., Corbett, M. A., Gardner, A. E., . . . Gecz, J. (2021). Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing. npj Genomic Medicine, 6(1), 74-1-74-11.
Scopus19 WoS9 Europe PMC142021 Richard, E. M., Bakhtiari, S., Marsh, A. P. L., Kaiyrzhanov, R., Wagner, M., Shetty, S., . . . Kruer, M. C. (2021). Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. American Journal of Human Genetics, 108(10), 2006-2016.
Scopus13 WoS5 Europe PMC122021 Jin, S. C., Lewis, S. A., Bakhtiari, S., Zeng, X., Sierant, M. C., Shetty, S., . . . Kruer, M. C. (2021). Author Correction: Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.. Nat Genet, 53(3), 412.
Scopus22021 Maclennan, A. H. (2021). All cases of cerebral palsy warrant genomic screening. Developmental Medicine and Child Neurology, 63(12), 1369.
Scopus1 WoS12020 Pham, R., Mol, B. W., Gecz, J., MacLennan, A. H., MacLennan, S. C., Corbett, M. A., . . . Berry, J. G. (2020). Definition and diagnosis of cerebral palsy in genetic studies: a systematic review. Developmental Medicine and Child Neurology, 62(9), 1024-1030.
Scopus21 WoS14 Europe PMC132020 Jin, S. C., Lewis, S. A., Bakhtiari, S., Zeng, X., Sierant, M. C., Shetty, S., . . . Kruer, M. C. (2020). Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics, 52(10), 1046-1056.
Scopus113 WoS71 Europe PMC682019 Helbig, K. L., Lauerer, R. J., Bahr, J. C., Souza, I. A., Myers, C. T., Uysal, B., . . . Jacobsen, J. C. (2019). Erratum: De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (The American Journal of Human Genetics (2018) 103(5) (666–678), (S0002929718303173), (10.1016/j.ajhg.2018.09.006)). American Journal of Human Genetics, 104(3), 562.
Scopus8 WoS5 Europe PMC42019 MacLennan, A. H., Lewis, S., Moreno-De-Luca, A., Fahey, M., Leventer, R. J., McIntyre, S., . . . Gecz, J. (2019). Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy. Journal of Child Neurology, 34(8), 472-476.
Scopus91 WoS51 Europe PMC412019 Corbett, M. A., van Eyk, C. L., Webber, D. L., Bent, S. J., Newman, M., Harper, K., . . . Gecz, J. (2019). Author Correction: Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy (npj Genomic Medicine, (2018), 3, 1, (33), 10.1038/s41525-018-0073-4). npj Genomic Medicine, 4(1), 1 page.
WoS2 Europe PMC12019 Braillon, A., Maclennan, A., Marron, L., & Dervaux, A. (2019). Teaching midwives to poke with needles on non-existing meridians. Women and Birth, 32(2), e284-e285.
Scopus3 Europe PMC32019 van Eyk, C. L., Corbett, M. A., Frank, M. S. B., Webber, D. L., Newman, M., Berry, J. G., . . . Gecz, J. (2019). Targeted resequencing identifies genes with recurrent variation in cerebral palsy. npj Genomic Medicine, 4(1), 27-1-27-11.
Scopus21 WoS16 Europe PMC152018 Helbig, K. L., Lauerer, R. J., Bahr, J. C., Souza, I. A., Myers, C. T., Uysal, B., . . . Zamponi, G. W. (2018). De novo pathogenic variants in CACNA1E cause developmental and epileptic encephalopathy with contractures, macrocephaly, and dyskinesias. American journal of human genetics, 103(5), 666-678.
Scopus91 WoS61 Europe PMC572018 Corbett, M. A., van Eyk, C. L., Webber, D. L., Bent, S. J., Newman, M., Harper, K., . . . Gecz, J. (2018). Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy. npj Genomic Medicine, 3(1), 33-1-33-9.
Scopus36 WoS27 Europe PMC212018 MacLennan, A. H., Kruer, M. C., Baynam, G., Moreno-De-Luca, A., Wilson, Y. A., Zhu, C., . . . Gecz, J. (2018). Cerebral palsy and genomics: an international consortium. Developmental Medicine and Child Neurology, 60(2), 209-210.
Scopus20 WoS17 Europe PMC132018 Van Eyk, C., Corbett, M., Gardner, A., Van Bon, B., Broadbent, J., Harper, K., . . . Gecz, J. (2018). Analysis of 182 cerebral palsy transcriptomes points to dysregulation of trophic signalling pathways and overlap with autism. Translational Psychiatry, 8(1), 88 -1-88 -10.
Scopus23 WoS20 Europe PMC182018 MacLennan, A., Gecz, J., & Pérez-Jurado, L. (2018). A genomic cause of cerebral palsy should not change the clinical classification. Annals of Clinical and Translational Neurology, 5(8), 1011.
Scopus6 WoS5 Europe PMC12017 Fahey, M., Maclennan, A., Kretzschmar, D., Gecz, J., & Kruer, M. (2017). The genetic basis of cerebral palsy. Developmental Medicine and Child Neurology, 59(5), 462-469.
Scopus142 WoS90 Europe PMC632016 Maclennan, A. H., Thompson, S. C., & Gecz, J. (2016). Reply. American Journal of Obstetrics and Gynecology, 214(5), 671.
2015 McMichael, G., Bainbridge, M., Haan, E., Corbett, M., Gardner, A., Thompson, S., . . . MacLennan, A. (2015). Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Molecular Psychiatry, 20(2), 176-182.
Scopus172 WoS123 Europe PMC1042015 Maclennan, A. (2015). Letters to the editor. Menopause, 22(3), 361.
2015 MacLennan, A., Thompson, S., & Gecz, J. (2015). Cerebral palsy: causes, pathways, and the role of genetic variants. American Journal of Obstetrics and Gynecology, 213(6), 779-788.
Scopus311 WoS183 Europe PMC1332013 O'Callaghan, M., & MacLennan, A. (2013). Cesarean delivery and cerebral palsy: A systematic review and meta-analysis. Obstetrics and Gynecology, 122(6), 1169-1175.
Scopus40 WoS31 Europe PMC232013 McMichael, G., Haan, E., Gardner, A., Yap, T., Thompson, S., Ouvrier, R., . . . MacLennan, A. (2013). NKX2-1 mutation in a family diagnosed with ataxic dyskinetic cerebral palsy. European Journal of Medical Genetics, 56(9), 506-509.
Scopus16 WoS8 Europe PMC92013 O'Callaghan, M., MacLennan, A., McMichael, G., Haan, E., & Dekker, G. (2013). Single-nucleotide polymorphism associations with preterm delivery: a case-control replication study and meta-analysis. Pediatric Research, 74(4), 433-438.
Scopus8 WoS5 Europe PMC52013 McMichael, G., Girirajan, S., Moreno-De-Luca, A., Gecz, J., Shard, C., Nguyen, L., . . . MacLennan, A. (2013). Rare copy number variation in cerebral palsy. European Journal of Human Genetics, 22(1), 40-45.
Scopus65 WoS48 Europe PMC412013 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2013). Genetic and clinical contributions to cerebral palsy: A multi-variable analysis. Journal of Paediatrics and Child Health, 49(7), 575-581.
Scopus18 WoS9 Europe PMC82013 Hirata, H., McMichael, G., Haan, E., MacLennan, A., Yap, T., Nguyen, L., . . . Gecz, J. (2013). ZC4H2 mutations are associated with arthrogryposis multiplex congenita and intellectual disability through impairment of central and peripheral synaptic plasticity. American Journal of Human Genetics, 92(5), 681-695.
Scopus64 WoS57 Europe PMC432013 Avery, J., Stocks, N., Duggan, P., Braunack-Mayer, A., Taylor, A., Goldney, R., & MacLennan, A. (2013). Identifying the quality of life effects of urinary incontinence with depression in an Australian population. BMC Urology, 13(11), 2-9.
Scopus42 WoS39 Europe PMC252013 O'Callaghan, M., & MacLennan, A. (2013). Brain damage and maternal medication. American Journal of Obstetrics and Gynecology, 208(2), 160-161.
2012 McMichael, G., MacLennan, A., Gibson, C., Alvino, E., Goldwater, P., Haan, E., & Dekker, G. (2012). Cytomegalovirus and Epstein–Barr virus may be associated with some cases of cerebral palsy. The Journal of Maternal - Fetal & Neonatal Medicine, 25(10), 2078-2081.
Scopus18 WoS10 Europe PMC62012 Purbrick, B., Stranks, K., Sum, C., & MacLennan, A. (2012). Future long-term trials of postmenopausal hormone replacement therapy: what is possible and what is the optimal protocol and regimen?. Climacteric, 15(3), 288-293.
Scopus4 WoS3 Europe PMC32012 Burger, H., MacLennan, A., Huang, K., & Castelo-Branco, C. (2012). Evidence-based assessment of the impact of the WHI on women's health. Climacteric, 15(3), 281-287.
Scopus54 WoS38 Europe PMC242012 Pines, A., Sturdee, D., & MacLennan, A. (2012). Quality of life and the role of menopausal hormone therapy. Climacteric, 15(3), 213-216.
Scopus25 WoS18 Europe PMC122012 MacLennan, A., & Morrison, R. (2012). Tertiary education institutions should not offer pseudoscientific medical courses: standing up for science. Medical Journal of Australia, 196(4), 225-226.
Scopus29 WoS24 Europe PMC122012 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2012). Fetal and maternal candidate single nucleotide polymorphism associations with Cerebral Palsy: a case-control study. Pediatrics, 129(2), E414-E423.
Scopus33 WoS23 Europe PMC192012 MacLennan, A., & MacLennan, A. (2012). Surgical menopause and early mortality in the California Teachers Study. Climacteric, 15(2), 203-204.
2011 MacLennan, A. (2011). A 'no-fault' cerebral palsy pension scheme would benefit all Australians. Australian & New Zealand Journal of Obstetrics & Gynaecology, 51(6), 479-484.
Scopus10 WoS8 Europe PMC62011 MacLennan, A., & Morris, D. (2011). Multiple choice in the management of the menopause. Climacteric, 14(6), 697-702.
2011 Archer, D., Sturdee, D., Baber, R., de Villiers, T., Pines, A., Freedman, R., . . . Warren, M. (2011). Menopausal hot flushes and night sweats: where are we now?. Climacteric, 14(5), 515-528.
Scopus165 WoS127 Europe PMC802011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). Epidemiologic associations with cerebral palsy. Obstetrics and Gynecology, 118(3), 576-582.
Scopus97 WoS85 Europe PMC572011 McMichael, G., Highet, A., Gibson, C., Goldwater, P., O'Callaghan, M., Alvino, E., & MacLennan, A. (2011). Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques, 22(1), 5-9.
Scopus7 Europe PMC42011 MacLennan, A. (2011). HRT in difficult circumstances: are there any absolute contraindications?. Climacteric, 14(4), 409-417.
Scopus22 WoS16 Europe PMC72011 Sturdee, D., Pines, A., Archer, D., Baber, R., Barlow, D., Birkhauser, M., . . . Stevenson, J. (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14(3), 302-320.
2011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). The Australian cerebral palsy research study - Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. Journal of Paediatrics and Child Health, 47(3), 99-110.
Scopus12 WoS9 Europe PMC72011 Wong, L., & MacLennan, A. (2011). Gathering the evidence: Cord gases and placental histology for births with low Apgar scores. Australian & New Zealand Journal of Obstetrics & Gynaecology, 51(1), 17-21.
Scopus20 WoS12 Europe PMC112011 Gibson, C., MacLennan, A., Haan, E., Priest, K., & Dekker, G. (2011). Fetal MBL2 haplotypes combined with viral exposure are associated with adverse pregnancy outcomes. The Journal of Maternal - Fetal & Neonatal Medicine, 24(6), 847-854.
Scopus11 WoS10 Europe PMC92010 MacLennan, A. (2010). The ascent of woman from Queen Adelaide to Queen Camilla. Australian & New Zealand Journal of Obstetrics & Gynaecology, 50(3), 211-215.
2010 Maclennan, A. (2010). The Causes of Cerebral Palsy in IVF and ART. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 50, 31-32. 2010 Maclennan, A., Sturdee, D., Fenton, A., & Panay, N. (2010). Editorial: Ghost writers, vested interest and funding disclosures. Climacteric, 13(4), 301-302.
Scopus2 Europe PMC12009 Welton, A. J., Vickers, M. R., Kim, J., Ford, D., Lawton, B. A., MacLennan, A. H., . . . Meade, T. W. (2009). Health-related quality of life after combined Hormone-Replacement therapy: Randomized controlled trial: Women's international study of long duration estrogen after the menopause. Obstetrical and Gynecological Survey, 64(4), 238-240.
Scopus32009 McMichael, G., Gibson, C., O'Callaghan, M., Goldwater, P., Dekker, G., Haan, E., & MacLennan, A. (2009). DNA from Buccal Swabs Suitable for High-Throughput SNP Multiplex Analysis. Journal of Biomolecular Techniques, 20(5), 232-235.
Scopus30 Europe PMC212009 MacLennan, A., & Baber, R. (2009). Hormone therapy use and risk of ovarian cancer. Jama-journal of the American Medical Association, 302(20), 2203.
Scopus4 WoS32009 MacLennan, A. (2009). Evidence-based review of therapies at the menopause. International Journal of Evidence-based Healthcare, 7(2), 112-123.
Scopus38 WoS28 Europe PMC172009 O'Callaghan, M., MacLennan, A., Haan, E., & Dekker, G. (2009). The genomic basis of cerebral palsy: A HuGE systematic literature review. Human Genetics, 126(1), 149-172.
Scopus49 WoS39 Europe PMC352009 Djukic, M., Gibson, C., MacLennan, A., Goldwater, P., Haan, E., McMichael, G., . . . Casey, G. (2009). Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 49(3), 247-253.
Scopus29 WoS27 Europe PMC202009 MacLennan, A., Gill, T., Broadbent, J., & Taylor, A. (2009). Continuing decline in hormone therapy use: population trends over 17 years. Climacteric, 12(2), 122-130.
Scopus33 WoS32 Europe PMC222009 MacLennan, A. H. (2009). Hormone replacement therapy: A 2008 perspective. Poloznictwo Ginekologia i Medycyna Rozrodu, 3(3), 183-190. 2009 Gibson, C. S., MacLennan, A. H., Dekker, G. A., Goldwater, P. N., Sullivan, T. R., Munroe, D. J., . . . Nelson, K. B. (2009). Candidate genes and cerebral palsy: A population-based study. Obstetrical and Gynecological Survey, 64(3), 154-155.
2008 MacLennan, A. H., & Sturdee, D. W. (2008). The use and abuse of screening tests around menopause. Medicine Today, 9(3), 15-17. 2008 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2008). Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. American Journal of Obstetrics and Gynecology, 198(5), 509.e1-509.e8.
Scopus20 WoS17 Europe PMC112008 Cummings, S., Ettinger, B., Delmas, P., Kenemans, P., Stathopoulos, V., Verweij, P., . . . MacLennan, A. (2008). The effects of tibolone in older postmenopausal women. New England Journal of Medicine, 359(7), 697-708.
2008 MacLennan, A. (2008). Hormone replacement therapy: a 2008 perspective. Obstetrics, Gynecology and Reproductive Medicine, 19(1), 13-18.
Scopus72008 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2008). Mannose binding lectin haplotypes are associated with cerebral palsy. American Journal of Obstetrics and Gynecology, 197(6 Suppl 1), S14.
WoS12008 MacLennan, A. (2008). Hormone replacement therapy reversal, revision and redemption. Medicine Today, 9(3), 18-28. 2008 Gibson, C., MacLennan, A., Goldwater, P., & Dekker, G. (2008). The antenatal causes of cerebral palsy - Genetic and viral associations. Fetal and Maternal Medicine Review, 19(3), 181-201.
Scopus12008 Gibson, C., MacLennan, A., Dekker, G., Goldwater, P., Sullivan, T., Munroe, D., . . . Nelson, K. (2008). Candidate Genes and Cerebral Palsy: A Population-Based Study. Pediatrics, 122(5), 1079-1085.
Scopus56 WoS44 Europe PMC392008 McMichael, G., Gibson, C., Goldwater, P., Haan, E., Priest, K., Dekker, G., & MacLennan, A. (2008). Association between apolipoprotein E genotype and cerebral palsy is not confirmed in a caucasian population. Human Genetics, 124(4), 411-416.
Scopus33 WoS28 Europe PMC232008 Welton, A., Vickers, M., Kim, J., Ford, D., Lawton, B., MacLennan, A., . . . Meade, T. (2008). Health related quality of life after combined hormone replacement therapy: randomised controlled trial. British Medical Journal, 337(7669), 550-553.
Scopus168 WoS114 Europe PMC872008 Schneider, H., MacLennan, A., & Feeny, D. (2008). Assessment of health-related quality of life in menopause and aging. Climacteric, 11(2), 93-107.
Scopus24 WoS23 Europe PMC152008 Paine, B., Stocks, N., & MacLennan, A. (2008). Seminars may increase recruitment to randomised controlled trials: lessons learned from WISDOM. Trials, 9(1), WWW 1-WWW 8.
Scopus10 WoS9 Europe PMC72008 Gibson, C., Goldwater, P., MacLennan, A., Haan, E., Priest, K., & Dekker, G. (2008). Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG, 115(4), 492-500.
Scopus57 WoS48 Europe PMC382007 Vickers, M., Martin, J., Meade, T., Wilkes, H., Ford, D., Walgrove, A., . . . MacLennan, A. (2007). The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Women's Health, 7(2), 1-17.
2007 Albertazzi, P., Barlow, D., Berry, E., Birkhauser, M., Bocker, W., Brincat, M., . . . Sturdee, D. (2007). IMS Updated recommendations on postmenopausal hormone therapy. Climacteric, 2007(10), 181-194.
2007 MacLennan, A., & Sturdee, D. (2007). Time for evidence-based labelling of over-the-counter medicines. Climacteric, 10(3), 179-180.
Scopus2 Europe PMC12007 MacLennan, A. (2007). HRT: a reappraisal of the risks and benefits. Medical Journal of Australia, 186(12), 643-646.
Scopus19 WoS16 Europe PMC112007 Gibson, C., MacLennan, A., Dekker, G., Goldwater, P., Dambrosia, J., Munroe, D., . . . Nelson, K. (2007). Genetic polymorphisms and spontaneous preterm birth. Obstetrics and Gynecology, 109(2 Part 1), 384-391.
Scopus60 WoS51 Europe PMC442007 Vickers, M., MacLennan, A., Lawton, B., Ford, D., Martin, J., Meredith, S., . . . Meade, T. (2007). Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. British Medical Journal, 335(239), 1-12.
Scopus211 WoS168 Europe PMC1152007 Sturdee, D. W., & MacLennan, A. H. (2007). A decade of swings and arrows. Climacteric, 10(6), 443-445.
Scopus12007 Sturdee, D. W., & MacLennan, A. H. (2007). The weight problem. Climacteric, 10(2), 83-84.
Scopus12007 MacLennan, A. H., & Sturdee, D. W. (2007). The impact of a decade of Climacteric. Climacteric, 10(5), 355.
2007 Pines, A., Sturdee, D. W., MacLennan, A. H., Schneider, H. P. G., Burger, H., & Fenton, A. (2007). The heart of the WHI study: Time for hormone therapy policies to be revised. Climacteric, 10(4), 267-269.
Scopus24 Europe PMC162007 MacLennan, A. H., & Sturdee, D. W. (2007). Long-term trials of HRT for cardioprotection - Is this as good as it gets?. Climacteric, 10(1), 1-4.
Scopus6 Europe PMC42006 Gibson, C. S., MacLennan, A. H., Goldwater, P. N., Haan, E. A., Priest, K., & Dekker, G. A. (2006). Neurotrophic viruses and cerebral palsy: Population based case - Control study: Commentary. Obstetrical and Gynecological Survey, 61(6), 359-360.
2006 MacLennan, A. (2006). Cerebral palsy and obstetric intervention. MedicSA, 19(10), 28-29. 2006 MacLennan, A., & Sturdee, D. (2006). Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?. Climacteric, 9(5), 321-322.
Scopus4 Europe PMC32006 Sturdee, D., & MacLennan, A. (2006). Reducing the problems of the progestogen. Climacteric, 9(4), 241-243.
Scopus3 Europe PMC42006 O'Neill, S., MacLennan, A., Bass, S., Diamond, T., Ebeling, P., Findlay, D., . . . Fiatarone-Singh, M. (2006). Wytyczne postępowania z osteoporozą omenopauzalną dla lekarzy rodzinnych. Lekarz Rodzinny, 4(104), 444-455. 2006 MacLennan, A., Hankins, G., & Speer, M. (2006). Only an expert witness can prevent cerebral palsy!. O & G, 8(1), 28-30. 2006 MacLennan, A. (2006). A 41-year-old woman with premature menopause. Medicine Today, 7(2), 62-64. 2006 MacLennan, A., & Sturdee, D. (2006). The 'bioidentical/bioequivalent' hormone scam. Climacteric, 9(1), 1-3.
Scopus17 Europe PMC152006 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2006). Neurotropic viruses and cerebral palsy: population based case-control study. British Medical Journal, 332(7533), 76-79.
Scopus71 WoS56 Europe PMC352006 Sturdee, D., & MacLennan, A. (2006). Not all placebos are equally pleasing. Climacteric, 9(6), 401-403.
Scopus4 WoS3 Europe PMC32006 MacLennan, A., & Sturdee, D. (2006). The use and abuse of screening tests around menopause. Climacteric, 9(3), 153-155.
Scopus2 WoS1 Europe PMC12006 Sturdee, D., & MacLennan, A. (2006). The pendulum swings back; estrogen is now beneficial if started at the right time. Climacteric, 9(2), 73-74.
Scopus12 WoS9 Europe PMC82006 MacLennan, A., Nelson, K., Hankins, G., & Speer, M. (2006). Cerebral palsy litigation - Reply. Jama-journal of the American Medical Association, 295(6), 626.
WoS12006 Hankins, G., MacLennan, A., Speer, M., Strunk, A., & Nelson, K. (2006). Obstetric litigation is asphyxiating our maternity services. Obstetrics and Gynecology, 107(6), 1382-1385.
Scopus36 WoS34 Europe PMC222006 Conlin, M., MacLennan, A., & Broadbent, J. (2006). Inadequate compliance with periconceptional folic acid supplementation in South Australia. Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(6), 528-533.
Scopus28 WoS27 Europe PMC192006 Strijbis, E., Oudman, I., van Essen, P., & MacLennan, A. (2006). Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstetrics and Gynecology, 107(6), 1357-1365.
Scopus101 WoS56 Europe PMC402006 Gibson, C., MacLennan, A., Janssen, N., Kist, W., Hague, W., Haan, E., . . . Dekker, G. (2006). Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology, 194(4), 947e1-947e10.
Scopus37 WoS25 Europe PMC132006 MacLennan, A., Myers, S., & Taylor, A. (2006). The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Medical Journal of Australia, 184(1), 27-31.
Scopus373 WoS300 Europe PMC1762006 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., Dekker, G., . . . Morton, M. (2006). The association between inherited cytokine polymorphisms and cerebral palsy. American Journal of Obstetrics and Gynecology, 194(3), 674e1-674e11.
Scopus61 WoS38 Europe PMC332006 Taylor, A., MacLennan, A., & Avery, J. (2006). Postmenopausal hormone therapy: Who now takes it and do they differ from non-users?. Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(2), 128-135.
Scopus17 WoS16 Europe PMC112006 MacLennan, A., Henderson, V., Paine, B., Mathias, J., Ramsay, E., Ryan, P., . . . Taylor, A. (2006). Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause-The Journal of the North American Menopause Society, 13(1), 28-36.
Scopus140 WoS121 Europe PMC882005 Sturdee, D., & MacLennan, A. (2005). How low can you go?. Climacteric, 8(4), 305-306.
2005 Norman, R., & MacLennan, A. (2005). Current status of hormone therapy and breast cancer. Human Reproduction Update, 11(6), 541-543.
Scopus12 WoS8 Europe PMC42005 MacLennan, A., Nelson, K., Hankins, G., & Speer, M. (2005). Who will deliver our grandchildren? Implications of cerebral palsy litigation. Jama-journal of the American Medical Association, 294(13), 1688-1690.
Scopus93 WoS67 Europe PMC422005 Gibson, C., MacLennan, A., Hague, W., Haan, E., Priest, K., Chan, A., & Dekker, G. (2005). Associations between inherited thrombophilias, gestational age, and cerebral palsy. American Journal of Obstetrics and Gynecology, 193(4), 1437.e1-1437.e12.
Scopus60 WoS42 Europe PMC342005 Gibson, C., MacLennan, A., Rudzki, Z., Hague, W., Haan, E., Sharpe, P., . . . Khong, T. (2005). The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology, 37(2), 160-163.
Scopus26 WoS22 Europe PMC172005 Sturdee, D., & MacLennan, A. (2005). Prevention of osteoporosis is still a valid aim for hormone therapy. Climacteric, 8(2), 97-98.
Scopus9 Europe PMC42005 MacLennan, A., & Sturdee, D. (2005). Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies. Climacteric, 8(1), 1-2.
Scopus6 Europe PMC62005 MacLennan, A. H., & Sturdee, D. W. (2005). Climacteric - The Journal of Adult Women's Health & Medicine. Climacteric, 8(3), 201-202.
2004 MacLennan, A., & Sturdee, D. W. (2004). Erratum: WHI, WHI, WHI? (Climacteric (2004) 7 (221-224)). Climacteric, 7(4). 2004 Sturdee, D., & MacLennan, A. (2004). Evolution and revolution at the menopause. Climacteric, 7(4), 325-326.
Scopus2 Europe PMC12004 MacLennan, A., & Sturdee, D. (2004). WHI, WHI, WHI?. Climacteric, 7(3), 221-224.
Scopus3 Europe PMC52004 MacLennan, A., Broadbent, J., Lester, S., & Moore, V. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes (review). The Cochrane Database of Systematic Reviews, 4(CD002978), 1-106.
Scopus541 WoS122 Europe PMC1272004 MacLennan, A., & Sturdee, D. (2004). Publishing the results of the estrogen-only arm of WHI. Climacteric, 7(2), 117-119.
Scopus2 Europe PMC12004 Sturdee, D., & MacLennan, A. (2004). Should epidemiology, the media and quangos determine clinical practice?. Climacteric, 7(1), 1-2.
Scopus12 Europe PMC102004 MacLennan, A., & Sturdee, D. (2004). WHI WHI WHI? Clarifying the interpretations of data from the Women's Health Initiative trial. O & G, 6(4), 298-300. 2004 O'Neill, S., MacLennan, A., Diamond, T., Ebeling, P., Findlay, D., Flicker, L., . . . Fiatarone-Singh, M. (2004). Guidelines for the management of postmenopausal osteoporosis for GPs. Australian Family Physician, 33(11), 910-919.
Scopus35 Europe PMC182004 MacLennan, A., & Robinson, J. (2004). Cerebral palsy and clinical negligence litigation: a cohort study. BJOG, 111(1), 92-93.
Scopus5 WoS4 Europe PMC22004 Avery, J., Gill, T., MacLennan, A., Chittleborough, C., Grant, J., & Taylor, A. (2004). The impact of incontinence on health-related quality of life in a South Australian population sample. Australian Health Review, 28(2), 173-179.
Scopus22 WoS19 Europe PMC132004 MacLennan, A. (2004). The trials and tribulations of long-term postmenopausal hormone therapy. Obstetrical & Gynecological Survey, 59(2), 65-67.
Scopus1 WoS22004 Paine, B., Stocks, N., Ramsay, E., Ryan, P., & MacLennan, A. (2004). Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants. Climacteric, 7(2), 143-152.
Scopus11 WoS9 Europe PMC62004 MacLennan, A., Taylor, A., & Wilson, D. (2004). Hormone therapy use after the Women's Health Initiative. Climacteric, 7(2), 138-142.
Scopus55 WoS48 Europe PMC362003 MacLennan, A., Taylor, A., Wilson, D., & Wilson, D. (2003). The prevalence of pelvic floor disorders and their relationship to gender, age and mode of delivery - reply. BJOG, 110(1), 88-89.
WoS2 Europe PMC12003 Gibson, C., MacLennan, A., Goldwater, P., & Dekker, G. (2003). Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection. Obstetrical & Gynecological Survey, 58(3), 209-220.
Scopus56 WoS33 Europe PMC212003 MacLennan, A. (2003). Hormone replacement therapy: where to now?. Australian Prescriber, 26(1), 8-10.
Scopus12003 MacLennan, A., & Sturdee, D. (2003). Time for new long-term trials of postmenopausal hormone therapies!. Climacteric, 6(4), 265-267.
Scopus4 Europe PMC12003 Sturdee, D., & MacLennan, A. (2003). Is combined estrogen/progestogen hormone therapy worth the risk?. Climacteric, 6(3), 177-179.
Scopus2 Europe PMC12003 MacLennan, A., & Sturdee, D. (2003). Is hormone therapy still an option for the management of osteoporosis?. Climacteric, 6(2), 89-91.
Scopus5 Europe PMC22003 Sturdee, D. W., & MacLennan, A. (2003). HT or HRT, that is the question?. Climacteric, 6(1), 1.
Scopus10 Europe PMC72002 O'Neill, S., Sambrook, P., Diamond, T., Ebeling, P., Ferris, L., Flicker, L., . . . Williamson, M. (2002). Guidelines for the treatment of postmenopausal osteoporosis for general practitioners.. Australian family physician, 31(10), 921-928.
Scopus82002 Homer, C., Eckert, K., Turnbull, D., & MacLennan, A. (2002). Immersion in water during first stage of labor [2] (multiple letters). Birth, 29(1), 76-77.
2002 MacLennan, A. H., Lawton, B., Baber, R. J., Baum, M., & Dixon, J. M. (2002). Hormone replacement therapy and the breast [6] (multiple letters). British Medical Journal, 324(7342), 915-916.
Scopus12002 O'Neill, S., Sambrook, P., Diamond, T., Ebeling, P., Ferris, L., Flicker, L., . . . Williamson, M. (2002). Guidelines for the treatment of postmenopausal osteoporosis for general practitioners. Australian Family Physician, 31(10), 921-928.
Scopus9 Europe PMC32002 Sturdee, D., & MacLennan, A. (2002). Primum non nocere. Climacteric, 5(3), 209-210.
Scopus4 Europe PMC22002 MacLennan, A. (2002). A scent of a woman. Climacteric, 5(2), 105-106.
2002 MacLennan, A., & Spencer, M. (2002). Who will deliver the next generation of Australians?. O & G, 4(3), 208-209. 2002 Eckert, K., Turnbull, D., & MacLennan, A. (2002). Immersion in water during first stage of labor - Reply. Birth-issues in Perinatal Care, 29(1), 77.
2002 MacLennan, A., & Sturdee, D. (2002). The end of WISDOM. Climacteric, 5(4), 313-316.
Scopus19 WoS13 Europe PMC122002 MacLennan, A., Lawton, B., & Baber, R. (2002). Hormone replacement therapy and the breast - Studies must determine the evidence. British Medical Journal, 324(7342), 915-916.
Scopus4 WoS4 Europe PMC32002 MacLennan, A., Wilson, D., & Taylor, A. (2002). Hormone replacement therapy use over a decade in an Australian population. Climacteric, 5(4), 351-356.
Scopus18 WoS14 Europe PMC102002 Hepworth, J., Paine, B., Miles, H., Marley, J., & MacLennan, A. (2002). The willingness of women to participate in a long-term trial of hormone replacement therapy: a qualitative study using focus groups. Psychology, Health & Medicine, 7(4), 469-476.
Scopus82002 Stapleton, D., MacLennan, A., & Kristiansson, P. (2002). The prevalence of recalled low back pain during and after pregnancy: a South Australian population survey. Australian & New Zealand Journal of Obstetrics & Gynaecology, 42(5), 482-485.
Scopus69 WoS49 Europe PMC322002 MacLennan, A., Wilson, D., & Taylor, A. (2002). The escalating cost and prevalence of alternative medicine. Preventive Medicine, 35(2), 166-173.
Scopus434 WoS331 Europe PMC2282002 MacLennan, A., & Spencer, M. (2002). Projections of Australian obstetricians ceasing practice and the reasons. Medical Journal of Australia, 176(9), 425-428.
Scopus29 WoS29 Europe PMC152001 Spencer, M., & MacLennan, A. (2001). Reply from the authors. Australian & New Zealand Journal of Obstetrics & Gynaecology, 41(3), 355.
WoS12001 MacLennan, A. (2001). A guest editorial from abroad: Medicolegal opinion - Time for peer review. Obstetrical & Gynecological Survey, 56(3), 121-123.
Scopus3 WoS3 Europe PMC32001 MacLennan, A. (2001). The ascent of woman. Climacteric, 4(4), 265-266.
2001 Cabrol, D., Gillett, J., Madelenat, P., Lansac, J., Paniel, B., Dellenbach, P., . . . Permezel, J. (2001). Treatment of preterm labor with the oxytocin antagonist atosiban: a double-bind, randomized, controlled comparison with salbutamol. European Journal of Obstetrics Gynecology and Reproductive Biology, 98(2), 177-185.
Scopus84 WoS62 Europe PMC472001 Moutquin, J., Cabrol, D., Fisk, N., MacLennan, A., Marsal, K., & Rabinovici, J. (2001). Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. British Journal of Obstetrics and Gynaecology, 108(2), 133-142.
WoS1822001 Diamond, T., Sambrook, P., Williamson, M., Flicker, L., Nowson, C., Fiatarone-Singh, M., . . . MacLennan, A. (2001). Men and osteoporosis. Australian Family Physician, 30(8), 781-785.
Scopus6 Europe PMC32001 MacLennan, A. (2001). For how long should a woman take hormone replacement therapy?. Middle East Fertility Society Journal, 6(1), 9-12. 2001 Diamond, T., Sambrook, P., Williamson, M., Flicker, L., Nowson, C., Fiatarone-Singh, M., . . . MacLennan, A. (2001). Guidelines for treatment of osteoporosis in men. Australian Family Physician, 30(8), 787-791.
Scopus16 Europe PMC72001 Sambrook, P., Diamond, T., Ferris, L., Fiatarone-Singh, M., Flicker, L., MacLennan, A., . . . Greville, H. (2001). Corticosteroid induced osteoporosis. Australian Family Physician, 30(8), 793-796. 2001 MacLennan, A., Lester, S., & Moore, V. (2001). Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric, 4(1), 58-74.
Scopus157 Europe PMC822001 Eckert, K., Turnbull, D., & MacLennan, A. (2001). Immersion in water in the first stage of labor: A randomized controlled trial. Birth-issues in Perinatal Care, 28(2), 84-93.
Scopus61 WoS45 Europe PMC322001 Spencer, M., & MacLennan, A. (2001). How long does it take to deliver a baby by emergency Caesarean section?. Australian & New Zealand Journal of Obstetrics & Gynaecology, 41(1), 7-11.
Scopus42 WoS35 Europe PMC252001 MacLennan, A., Lester, S., & Moore, V. (2001). Oral oestrogen replacement therapy versus placebo for hot flushes.. Cochrane database of systematic reviews (Online), (1), CD002978.
Scopus145 Europe PMC102001 Eckert, K., Turnbull, D., & MacLennan, A. (2001). Warm water bathing did not reduce use of pharmacological analgesia during the first stage of labour. Evidence-Based Medicine, 6(6), 177.
Scopus12001 Moutquin, J. M., Cabrol, D., Fisk, N. M., MacLennan, A. H., Maršál, K., & Rabinovici, J. (2001). Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. British Journal of Obstetrics and Gynaecology, 108(2), 133-142.
Scopus254 Europe PMC822001 Chui, Y. K., Thijs, I., Bhal, P. S., Spencer, M., & MacLennan, A. (2001). Letter to the editor (multiple letters). Australian and New Zealand Journal of Obstetrics and Gynaecology, 41(3), 355. 2001 MacLennan, A. (2001). Index Medicus and MEDLINE indexing for Climacteric. Climacteric, 4(2), 89-90.
2001 Sambrook, P. N., Diamond, T., Ferris, L., Fiatarone-Singh, M., Flicker, L., MacLennan, A., . . . Greville, H. (2001). Corticosteroid induced osteoporosis. Guidelines for treatment.. Australian family physician, 30(8), 793-796.
Scopus30 Europe PMC112000 Sambrook, P., O'Neill, S., Diamond, T., Flicker, L., & MacLennan, A. (2000). Postmenopausal osteoporosis treatment guidelines.. Australian family physician, 29(8), 751-758.
Scopus8 Europe PMC22000 MacLennan, A. (2000). A template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement (Reprinted from British Medical Journal, vol 319, pg 1054-1059, 1999). AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 40(1), 13-21.
WoS142000 MacLennan, A. H. (2000). Advertising standards for the complimentary medicines at the climacteric. Climacteric, 3(2), 81-83.
Scopus4 Europe PMC22000 MacLennan, A., & Baber, R. (2000). The role of oestrogen in cardiovascular disease: benefit or harm?. Medical Journal of Australia, 172(7), 347-348.
2000 MacLennan, A. (2000). Establishing probable cause in cerebral palsy - There are problems with the consensus statement - Reply. British Medical Journal, 320(7241), 1076.
Scopus13 Europe PMC42000 MacLennan, A. (2000). The descent of woman. Climacteric, 3(4), 225-226.
Scopus8 Europe PMC42000 MacLennan, A., Taylor, A., Wilson, D., & Wilson, D. (2000). The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. British Journal of Obstetrics and Gynaecology, 107(12), 1460-1470.
Scopus751 WoS587 Europe PMC4222000 Spencer, M., Khong, T., Matthews, B., & MacLennan, A. (2000). Haematopoietic indicators of fetal metabolic acidosis. Australian & New Zealand Journal of Obstetrics & Gynaecology, 40(3), 286-289.
Scopus10 WoS8 Europe PMC52000 MacLennan, A. (2000). Long-term hormone replacement therapy. Australian Prescriber, 23(5), 90-92.
Scopus62000 MacLennan, A., Paine, B., & Marley, J. (2000). WISDOM Will Australian women participate?. Australian Family Physician, 29(8), 797-801.
Scopus3 Europe PMC12000 MacLennan, A. (2000). Risk management in cerebral palsy. O & G / Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2(2), 88-92. 1999 Guthrie, J., Garamszegi, C., Dudley, E., Dennerstein, L., Green, A., MacLennan, A., & Burger, H. (1999). Hormone therapy use in Australian-born women: a longitudinal study. Medical Journal of Australia, 171(7), 358-361.
Scopus6 WoS5 Europe PMC31999 MacLennan, A., Wilson, D., & Taylor, A. (1999). Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997. Medical Journal of Australia, 170(11), 524-527.
Scopus15 WoS13 Europe PMC41999 MacLennan, A. (1999). A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. British Medical Journal, 319(7216), 1054-1059.
Scopus616 WoS473 Europe PMC3011999 Nand, S. L., Wren, B. G., Gross, B. A., Heller, G. Z., Webster, M., Baber, R., . . . Wenzel, S. (1999). Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Obstetrics and Gynecology, 93(6), 1009-1013.
Scopus10 Europe PMC21999 Maclennan, A. H. (1999). Climacteric news. Climacteric, 2(4), 247.
1999 MacLennan, A., & Pasternak, J. F. (1999). Acute near-total intrauterine asphyxia. Pediatric Neurology, 20(1), 81-82.
Scopus6 WoS5 Europe PMC11999 MacLennan, A. H. (1999). The four harms of harmless therapies: Editorial. Climacteric, 2(2), 73-74.
Scopus15 Europe PMC141999 Peverill, R. E., Harper, R. W., MacLennan, A. H., Wilson, D. H., & Taylor, A. W. (1999). Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997 (multiple letters) [1]. Medical Journal of Australia, 171(5), 275.
1998 Maclennan, A. H. (1998). Happy Birthday, Climacterid. Climacteric, 1(4), 257.
1998 MacLennan, A. H., & Sturdee, D. W. (1998). The change to Climacteric.. Climacteric : the journal of the International Menopause Society, 1(1), 3-4.
Scopus3 Europe PMC21998 MacLennan, A. H. (1998). Cancer, cohorts, confounding and consensus.. Climacteric : the journal of the International Menopause Society, 1(2), 89-90.
Scopus2 Europe PMC21998 MacLennan, A. (1998). Editorial: Cancer cohorts, confounding and consensus. Climacteric, 1, 89-90. 1998 MacLennan, A., & Sturdee, D. (1998). Editorial: The change to Climacteric. Climacteric, 1, 3-4. 1998 Farquhar, C., & MacLennan, A. (1998). Where is the evidence for effectiveness of treatments for the menopause? Introducing the Cochrane Collaboration. Climacteric, 1(1), 5-11.
Scopus3 Europe PMC11998 MacLennan, A., Wilson, D., & Taylor, A. (1998). Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion. Climacteric, 1(1), 42-49.
Scopus26 Europe PMC151998 Wilson, D., Taylor, A., & MacLennan, A. (1998). Health status of hormone replacement therapy users and non-users as determined by the SF-36 quality-of-life dimension. Climacteric, 1(1), 50-54.
Scopus15 Europe PMC101998 MacLennan, A. (1998). The management of progestogenic side-effects. Changes / Australasian Menopause Society, 98(2), 5-7. 1998 MacLennan, A. (1998). HRT and breast cancer: is there a link?. Modern Medicine of Australia, 41(9), 17-19. 1998 MacLennan, A. (1998). The Perimenopause - Questions of Management. Current Therapeutics, 39(June), 47-49. 1997 MacLennan, A. (1997). HRT and Breast Cancer. Skeptic, 17, 57-58. 1997 MacLennan, A., & MacLennan, S. (1997). Symptom-giving pelvic girdle relaxation of pregnancy, postnatal pelvic joint syndrome and developmental dysplasia of the hip. Acta Obstetrica et Gynecologica Scandinavica, 76(8), 760-764.
Scopus70 WoS50 Europe PMC311997 MacLennan, A. (1997). Osteoporosis. Menopause and beyond.. Australian family physician, 26(2), 123-131.
Scopus2 Europe PMC11996 Thijssen, J. H. H., & MacLennan, A. H. (1996). Untitled. MATURITAS, 25(2), 85-86.
1996 Kricker, A., Armstrong, B. K., Prince, R. L., Geelhoed, E. A., Zalcberg, J. R., Siderov, J., . . . Smith, M. (1996). Hormone replacement therapy and breast cancer: What are the facts? [1]. Medical Journal of Australia, 164(6), 379-380.
1996 MacLennan, A., Wilson, D., & Taylor, A. (1996). The self-reported prevalence of postnatal depression.. The Australian & New Zealand journal of obstetrics & gynaecology, 36(3), 313.
Scopus9 WoS16 Europe PMC91996 MacLennan, A., Wilson, D., & Taylor, A. (1996). A statement concerning postnatal depression. The self-reported prevalence of postnatal depression. Australian and New Zealand Journal of Obstetrics and Gynaecology, 36(3), 313.
Scopus251996 MacLennan, A. H., & Smith, M. (1996). Hormone replacement therapy and breast cancer: What are the facts? Reply. MEDICAL JOURNAL OF AUSTRALIA, 164(6), 380.
1996 MacLennan, A., Wilson, D., & Taylor, A. (1996). Prevalence and cost of alternative medicine in Australia. Lancet, 347(9001), 569-573.
Scopus826 WoS667 Europe PMC4511996 MacLennan, A. (1996). Menstrual irregularity and menopause. Current Therapeutics, 37(7), 33-35. 1996 MacLennan, A. (1996). Pill, patch or pellet! What's new in HRT?. South Australian Medical Review, 9(12), 33-35. 1995 MacLennan, A., Stanley, F., Blair, E., Rice, G., Stone, P., Robinson, J., . . . Kenny, M. (1995). The origins of cerebral palsy - A consensus statement. Medical Journal of Australia, 162(2), 85-90.
Scopus33 WoS32 Europe PMC41995 MacLennan, S., MacLennan, A., & Ryan, P. (1995). Colorectal cancer and oestrogen replacement therapy, a meta analysis of the epidemiological studies. Medical Journal of Australia, 162(9), 491-493.
Scopus46 WoS43 Europe PMC161995 MacLennan, A., & Smith, M. (1995). Hormone replacement therapy and breast cancer: What are the facts?. Medical Journal of Australia, 163(9), 483-485.
Scopus3 WoS51995 MacLennan, A., Taylor, A., & Wilson, D. (1995). Changes in the use of hormone replacement therapy in South Australia. Medical Journal of Australia, 162(8), 420-422.
Scopus30 WoS29 Europe PMC131995 MacLennan, A. (1995). Benefits of sustained oestrogen therapy. Current Therapeutics, 36(3), 107. 1995 MacLennan, A., Grant, P., & Bryant-Greenwood, G. (1995). hRLX-1 in vitro response of human and pig myometrium. Journal of Reproductive Medicine, 40(10), 703-706.
Scopus19 WoS19 Europe PMC91995 MACLENNAN, A. H., STANLEY, F., BLAIR, E., RICE, G., STONE, P., ROBINSON, J., . . . KENNY, M. (1995). THE ORIGINS OF CEREBRAL-PALSY. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 31(4), 284-289.
WoS11995 MACLENNAN, A., STANLEY, F., BLAIR, E., RICE, G., STONE, P., ROBINSON, J., . . . KENNY, M. (1995). CONSENSUS STATEMENT ON THE ORIGINS OF CEREBRAL-PALSY. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 35(2), 126-131.
1994 MacLennan, A. H., Chan, F. Y., & Eckert, K. (1994). The Safety of Vaginal Prostaglandin F<inf>2</inf>α for the Stimulation of Labour. Australian and New Zealand Journal of Obstetrics and Gynaecology, 34(2), 154-158.
Scopus3 WoS41994 Maclennan, A. H., Crowther, C., & Derham, R. (1994). Does the option to ambulate during spontaneous labour confer any advantage or disadvantage?. Journal of Maternal-Fetal and Neonatal Medicine, 3(1), 43-48.
Scopus141993 MacLennan, A. H. (1993). 12 Running a menopause clinic. Bailliere's Clinical Endocrinology and Metabolism, 7(1), 243-253.
Scopus4 WoS61993 MacLennan, A. H., MacLennan, A., Wenzel, S., Chambers, H. M., & Eckert, K. (1993). Continuous low-dose oestrogen and progestogen hormone replacement therapy: A randomised trial. Medical Journal of Australia, 159(2), 102-106.
Scopus58 WoS42 Europe PMC281993 Brännström, M., & Maclennan, A. H. (1993). Relaxin induces ovulations in the in-vitro perfused rat ovary. Human Reproduction, 8(7), 1011-1014.
Scopus23 WoS20 Europe PMC111993 MacLennan, A. H., MacLennan, A., & Wilson, D. (1993). The prevalence of hysterectomy in South Australia. Medical Journal of Australia, 158(12), 807-809.
Scopus29 WoS24 Europe PMC171993 MacLennan, A. H., MacLennan, A., & Wilson, D. (1993). The prevalence of oestrogen replacement therapy in South Australia. Maturitas, 16(3), 175-183.
Scopus48 WoS41 Europe PMC271993 Norman, R. J., McLoughlin, J. W., Borthwick, G. M., Yohkaichiya, T., Matthews, C. D., MacLennan, A. H., & De Kretser, D. M. (1993). Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: Relationship to gonadotropin and steroid profiles. Fertility and Sterility, 59(1), 130-137.
Scopus27 WoS28 Europe PMC131993 MacLennan, A. H. (1993). Who will deliver the next generation?. Medical Journal of Australia, 159(4), 261-263.
Scopus10 WoS12 Europe PMC41993 Bell, R. J., Permezel, M., MacLennan, A., Hughes, C., Healy, D., & Brennecke, S. (1993). A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening. Obstetrics and Gynecology, 82(3), 328-333.
Scopus58 WoS50 Europe PMC311992 MacLennan, A. (1992). Women, cardiovascular disease and hormone replacement therapy. Medical Journal of Australia, 156(2), 77-78.
Scopus4 WoS6 Europe PMC21992 MacLennan, A. (1992). Transdermal oestrogen replacement therapy. Medical Journal of Australia, 156(10), 679-680.
Scopus11992 MacLennan, A. (1992). Menopause and preventive medicine.. Australian family physician, 21(3), 205. 1992 MacLennan, A. H., MacLennan, A., O'Neill, S., Kirkgard, Y., Wenzel, S., & Chambers, H. M. (1992). Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy. Medical Journal of Australia, 157(3), 167-170.
Scopus17 Europe PMC61992 Green, R. C., & MacLennan, A. H. (1992). Telephone Fetal Heart Rate Monitoring in South Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology, 32(2), 114-117.
Scopus5 WoS5 Europe PMC51992 MACLENNAN, A. H., MACLENNAN, A., ONEILL, S., KIRKGARD, Y., WENZEL, S., & CHAMBERS, H. M. (1992). ESTROGEN AND CYCLICAL PROGESTOGEN IN POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY. MEDICAL JOURNAL OF AUSTRALIA, 157(3), 167-170.
WoS111991 MacLennan, A. H. (1991). Hormone replacement therapy and the menopause. Medical Journal of Australia, 155(1), 43-44.
Scopus15 WoS121991 MACLENNAN, A. H. (1991). HORMONE REPLACEMENT THERAPY AND THE MENOPAUSE - REPLY. MEDICAL JOURNAL OF AUSTRALIA, 155(5), 351.
WoS11991 MacLennan, A. H., & Grant, P. (1991). Human relaxin: In vitro response of human and pig myometrium. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 36(9), 630-634.
Scopus25 WoS26 Europe PMC131991 MacLennan, A. H. (1991). Hormone replacement therapy and the menopause. Australian Menopause Society.. The Medical journal of Australia, 155(1), 43-44.
Europe PMC31991 MacLennan, A. H. (1991). The role of the hormone relaxin in human reproduction and pelvic girdle relaxation. Scandinavian Journal of Rheumatology, Supplement, 20(88), 7-15.
Scopus99 WoS69 Europe PMC331991 Maclennan, A. H., Grant, P., & Borthwick, A. C. (1991). Relaxin and relaxin c-peptide levels in human reproductive tissues. Reproduction, Fertility and Development, 3(5), 577-583.
Scopus16 WoS17 Europe PMC91991 Pervan, Z., & MacLennan, A. H. (1991). Hormone replacement therapy and the menopause [12]. Medical Journal of Australia, 155(5), 350-351.
1991 MacLennan, A. (1991). Genital persuasion: Prostaglandins for the induction of labour. Medical Journal of Australia, 155(1), 5-7.
Scopus2 WoS2 Europe PMC11990 Dreosti, I. E., & MacLennan, A. (1990). Maternal plasma zinc levels and first trimester abortion. Early Human Development, 21(2), 141-142.
Scopus7 WoS7 Europe PMC51990 MacLennan, A. H., Rodrigues, L. V., Krutli, D. R., & Klomp, A. (1990). Post-operative discomfort after ring or clip tubal ligation - is there any difference and do indomethacin suppositories help?. Contraception, 42(3), 309-313.
Scopus12 WoS10 Europe PMC51990 MacLennan, A. H., Green, R. C., Brookes, C., Morris, D., & O'Shea, R. (1990). Routine hospital admission in twin pregnancy between 26 and 30 weeks' gestation. The Lancet, 335(8684), 267-269.
Scopus49 WoS34 Europe PMC321990 Maclennan, A. H. (1990). Australian clinical trials with prostaglandins E2 and F2α to induce labour. Reproduction, Fertility and Development, 2(5), 557-561.
Scopus1 Europe PMC11990 MacLennan, A. H. (1990). Perineal pain after childbirth. Medical Journal of Australia, 152(1), 1-2.
Scopus2 WoS61990 MaClennan, A. H., Green, R. C., O'shea, R., Brookes, C., & Morris, D. (1990). Routine hospital admission in twin pregnancy between 26 and 30 weeks' gestation. Obstetrical and Gynecological Survey, 45(9), 604-605.
1989 Pupula, M., & MacLennan, A. H. (1989). Effect of porcine relaxin on spontaneous, oxytocin-driven and prostaglandin-driven pig myometrial activity in vitro. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 34(10), 819-823.
Scopus7 WoS7 Europe PMC31989 MacLennan, A., Fraser, I., Jakubowicz, D., Murray‐Arthur, F., Quinn, M., & Trudinger, B. (1989). Labour Induction with Low Dose PGE2 Vaginal Gel: Result of an Australian Multicentre Randomized Trial*. Australian and New Zealand Journal of Obstetrics and Gynaecology, 29(2), 124-128.
Scopus16 WoS13 Europe PMC81988 MacLennan, A. H. (1988). Current management of the menopause.. Australian family physician, 17(3), 158-169.
Scopus5 Europe PMC11988 GREEN, R. C. (1988). The Fetal Heart Response to Static Antenatal Exercises in the Supine Position. Australian Journal of Physiotherapy, 34(1), 3-7.
Scopus101987 Stone, B. A., Petrucco, O. M., Seamark, R. F., & MacLennan, A. H. (1987). Concentrations of steroid hormones, and of relaxin, in utero-ovarian venous plasma of periparturient sows. Animal Reproduction Science, 15(3-4), 227-239.
Scopus3 WoS31987 MacLennan, A. H. (1987). Oral contraceptives. Current Therapeutics, 28(12), 113-122.
Scopus21986 MacLennan, A. (1986). Optimum use of oral contraceptives. Current Therapeutics, 27(9), 37-48. 1986 Maclennan, A. H., Green, R. C., Grant, P., & Nicolson, R. (1986). Ripening of the human cervix and induction of labor with intracervical purified porcine relaxin. Obstetrics and Gynecology, 68(5), 598-601.
Scopus51 Europe PMC231986 Maclennan, A., Green, R., Nicolson, R., & Bath, M. (1986). Serum relaxin and pelvic pain of pregnancy. The Lancet, 328(8501), 243-245.
Scopus167 WoS136 Europe PMC711986 MacLennan, A. H., Grant, P., Ness, D., & Down, A. (1986). Effect of porcine relaxin and progesterone on rat, pig and human myometrial activity in vitro. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 31(1), 43-49.
Scopus27 WoS35 Europe PMC171986 MacLennan, A. H., Rippin, C., & Tiver, J. (1986). Obstetric Team Care by a Private Midwife and Obstetrician—A Pilot Trial. Australian and New Zealand Journal of Obstetrics and Gynaecology, 26(1), 40-44.
Scopus2 Europe PMC11986 Maclennan, A., Nicolson, R., & Green, R. (1986). Serum relaxin in pregnancy. The Lancet, 328(8501), 241-243.
Scopus55 WoS58 Europe PMC271986 Pupula, M., Quinn, P., & MacLennan, A. (1986). The effect of porcine relaxin on the fertilisation of mouse oocytes in vitro. Clinical Reproduction and Fertility, 4(6), 383-387.
Scopus17 Europe PMC51985 MacLennan, A. H., Katz, M., & Creasy, R. (1985). The morphologic characteristics of cervical ripening induced by the hormones relaxin and prostaglandin F<inf>2α</inf> in a rabbit model. American Journal of Obstetrics and Gynecology, 152(6), 691-696.
Scopus13 Europe PMC51985 Day, A., MacLennan, A., & Green, R. (1985). A Comparison of Intravaginal PGF<inf>2</inf>α and Intravenous Oxytocin to Stimulate Labour after Membrane Rupture. Australian and New Zealand Journal of Obstetrics and Gynaecology, 25(4), 252-255.
Scopus9 Europe PMC31985 MacLennan, A. H., Kerin, J. F. P., Kirby, C., Grant, P., Warnes, G. M., Cox, L. W., . . . Greenwood, F. (1985). The Effect of Porcine Relaxin Vaginally Applied at Human Embryo Transfer in an In Vitro Fertilization Programme. Australian and New Zealand Journal of Obstetrics and Gynaecology, 25(1), 68-71.
Scopus7 Europe PMC41984 Cheek, D. B., Wishart, J., MacLennan, A. H., & Haslam, R. (1984). Cell hydration in the normally grown, the premature and the low weight for gestational age infant. Early Human Development, 10(1-2), 75-84.
Scopus31 WoS30 Europe PMC91984 LUKACS, H. A., MacLENNAN, A. H., & VERCO, P. W. (1984). Ultrasonic fetal weight estimation in multiple and singleton pregnancy. Journal of Paediatrics and Child Health, 20(1), 59-61.
Scopus1 WoS21984 CHEEK, D. B., WISHART, J., MACLENNAN, A., & HASLAM, R. (1984). HYDRATION IN THE NEONATE DYSMATURE PREMATURE. AUSTRALIAN PAEDIATRIC JOURNAL, 20(4), 342. 1983 Rogers, P. A. W., Murphy, C. R., Squires, K. R., & MacLennan, A. H. (1983). Effects of relaxin on the intrauterine distribution and antimesometrial positioning and orientation of rat blastocysts before implantation. Journal of Reproduction and Fertility, 68(2), 431-435.
Scopus29 WoS30 Europe PMC121983 MacLennan, A. H., Hocking, A., Seamark, R. F., Godfrey, B., & Haslam, R. (1983). Neonatal water metabolism: an objective postnatal index of intrauterine fetal growth. Early Human Development, 8(1), 21-31.
Scopus7 WoS5 Europe PMC11983 MacLennan, A. H. (1983). The role of relaxin in human reproduction. Clinical Reproduction and Fertility, 2(2), 77-95.
Scopus27 Europe PMC161982 Cheek, D. B., Wishart, J., MacLennan, A. H., Haslam, R., & Fitzgerald, A. (1982). Hydration in the first 24 h of postnatal life in normal infants born vaginally or by caesarean section. Early Human Development, 7(4), 323-330.
Scopus21 WoS18 Europe PMC81982 Cooper, E., Anderson, A., Bennett, M. J., MacLennan, A. H., Stirrat, G. M., & Burke, C. W. (1982). Radioimmunoassay of thyroxine and 3,3',5'-triiodothyronine (reverse T3) in human amniotic fluid. Clinica Chimica Acta, 118(1), 57-66.
Scopus8 WoS8 Europe PMC31982 Burgoyne, J. L., Ballard, F. J., Tomas, F. M., Dobozy, A., MacLennan, A. H., Fitzgerald, A., & Dahlenburg, G. W. (1982). Measurements of myofibrillar protein breakdown in newborn human infants. Clinical Science, 63(5), 421-427.
Scopus11 WoS15 Europe PMC61981 MacLennan, A. H. (1981). Relaxin – A Review. Australian and New Zealand Journal of Obstetrics and Gynaecology, 21(4), 195-202.
Scopus18 WoS18 Europe PMC81981 MacLennan, A. H., Green, R. C., Bryant-Greenwood, G. D., Greenwood, F. C., & Seamark, R. F. (1981). Cervical ripening with combinations of vaginal prostaglandin F<inf>2α</inf>estradiol, and relaxin. Obstetrics and Gynecology, 58(5), 601-604.
Scopus28 WoS29 Europe PMC121981 MacLennan, A. H., Millington, G., Grieve, A., McIntosh, J. E. A., Seamark, R. F., & Cox, L. W. (1981). Neonatal body water turnover: A putative index of perinatal morbidity. American Journal of Obstetrics and Gynecology, 139(8), 948-952.
Scopus7 WoS5 Europe PMC31980 MacLennan, A. (1980). Pill prescription by potency: A simplified method of oral contraceptive selection. Current Therapeutics, 21(7), 45-50. 1980 MacLennan, A. (1980). Management of the hypertensive crisis in pregnancy. Current Therapeutics, 21(11), 63-73. 1980 MacLennan, A. (1980). Hormone replacement therapy: More facts and less fear. Current Therapeutics, 21(8), 11-15. 1980 MacLennan, A. H., & Green, R. C. (1980). The Effect of Intravaginal Prostaglandin F<inf>2α</inf> on Labour after Spontaneous and Artificial Rupture of the Membranes. Australian and New Zealand Journal of Obstetrics and Gynaecology, 20(2), 87-90.
Scopus14 WoS13 Europe PMC41980 Finikiotis, G., MacLennan, A. H., Verco, P. W., & Ogden, S. E. (1980). An Evaluation of Two Methods of Antenatal Ultrasonic Fetal Weight Estimation. Australian and New Zealand Journal of Obstetrics and Gynaecology, 20(3), 135-138.
Scopus10 WoS9 Europe PMC11980 Maclennan, A. H., Green, R. C., Bryant-Greenwood, G. D., Greenwood, F. C., & Seamark, R. F. (1980). RIPENING OF THE HUMAN CERVIX AND INDUCTION OF LABOUR WITH PURIFIED PORCINE RELAXIN. The Lancet, 315(8162), 220-223.
Scopus77 WoS98 Europe PMC281980 MaeLennan, A. H., & Green, R. C. (1980). A Double Blind Dose Trial of Intravaginal Prostaglandin F<inf>2α</inf> for Cervical Ripening and the Induction of Labour. Australian and New Zealand Journal of Obstetrics and Gynaecology, 20(2), 80-83.
Scopus15 WoS11 Europe PMC51980 FINIKIOTIS, G., MACLENNAN, A. H., VERCO, P. W., & OGDEN, S. E. (1980). ANTENATAL FETAL WEIGHT ESTIMATION BY ULTRASONOGRAPHY. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 20(3), 193. 1979 MACLENNAN, A. H., SEAMARK, R. F., GRIEVE, A. W., BRAYBROOK, R. C., & HENDERSON, C. (1979). NEONATAL BODY-WATER TURNOVER AS AN INDEX OF FETAL MORBIDITY. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 19(3), 180. 1979 MacLennan, A. H., & Green, R. C. (1979). Fetal Heart Rate Monitoring During Ambulant Labour Using a Modified Adult Radiotelemetry System. Australian and New Zealand Journal of Obstetrics and Gynaecology, 19(3), 135-138.
Scopus2 WoS4 Europe PMC11979 MACLENNAN, A. H., & GREEN, R. C. (1979). INTERVENTION IN LABOR WITHOUT INTERFERENCE - RADIOTELEMETRY AND VAGINAL PROSTAGLANDINS. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 19(3), 180-181. 1979 Maclennan, A. H., & Green, R. C. (1979). CERVICAL RIPENING AND INDUCTION OF LABOUR WITH INTRAVAGINAL PROSTAGLANDIN F<inf>2α</inf>. The Lancet, 313(8108), 117-119.
Scopus30 WoS23 Europe PMC171978 MACLENNAN, A. H. (1978). AUDIT OF OBSTETRIC PRACTICE IN MANAGEMENT OF LABOR. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 18(4), 287-288.
WoS11977 Cooper, E., Manning, D. M., MacLennan, A. H., & Burke, C. W. (1977). Thyroid hormones in human amniotic fluid: detection of tri-iodothyronine and free levels of thyroxine, tri-iodothyronine and 3,3',5'-tri-iodothyronine [proceedings]. Journal of Endocrinology, 73(3), P44.
Scopus5 WoS7 Europe PMC21977 Hoult, I. J., Maclennan, A. H., & Carrie, L. E. S. (1977). Lumbar epidural analgesia in labour: Relation to fetal malposition and instrumental delivery. British Medical Journal, 1(6052), 14-16.
Scopus130 WoS130 Europe PMC581976 MacLennan, A. H., Emerson, P. M., Hunter, D. J. S., & Darley, J. H. (1976). Tissue oxygenation and red cell 2,3-diphosphoglycerate in normal and abnormal pregnancy. British Journal of Obstetrics and Gynaecology, 83(5), 378-382.
Scopus9 WoS9 Europe PMC31976 Sklovsky, E., & MacLennan, A. H. (1976). Reliable detection of ruptured membranes. British Medical Journal, 2(6042), 1014.
Scopus2 WoS2 Europe PMC21975 MacLennan, A. H., Carty, M. J., Sheppard, B. L., & Sharp, F. (1975). An ultrastructural study of the reversibility of the effects of hypoxia on human trophoblast maintained in organ culture. Journal of Reproduction and Fertility, 43(3), 501-504.
Scopus3 WoS3 Europe PMC21975 MacLennan, A. H., Roxburgh, D., Thornton, C., Knightley, M., & Moore, R. A. (1975). PALMITIC ACID LEVELS IN AMNIOTIC FLUID AND THE SHAKE TEST. BJOG: An International Journal of Obstetrics & Gynaecology, 82(3), 199-203.
Scopus2 WoS51975 Moore, R. A., O'Neil, K. T. J., Cooke, R. J., & MacLennan, A. H. (1975). PALMITIC ACID AND LECITHIN MEASUREMENTS IN AMNIOTIC FLUID. BJOG: An International Journal of Obstetrics & Gynaecology, 82(3), 194-198.
Scopus12 WoS18 Europe PMC31972 MacLennan, A. H., Sharp, F., & Shaw-Dunn, J. (1972). The ultrastructure of human trophoblast in spontaneous and induced hypoxia using a system of organ culture. A comparison with uultrastructural changes in pre-eclampsia and placental insufficiency.. The Journal of obstetrics and gynaecology of the British Commonwealth, 79(2), 113-121.
Scopus16 Europe PMC91972 MacLennan, A. H., Sharp, F., & Shaw‐Dunn, J. (1972). THE ULTRASTRUCTURE OF HUMAN TROPHOBLAST IN SPONTANEOUS AND INDUCED HYPOXIA USING A SYSTEM OF ORGAN CULTURE: A Comparison with Ultrastructural Changes in Pre‐eclampsia and Placental Insufficiency. BJOG: An International Journal of Obstetrics & Gynaecology, 79(2), 113-121.
Scopus47 Europe PMC171971 Wynn, R. M., Panigel, M., & MacLennan, A. H. (1971). Fine structure of the placenta and fetal membranes of the baboon. American Journal of Obstetrics and Gynecology, 109(4), 638-648.
Scopus29 Europe PMC181971 Maclennan, A. H., & Wynn, R. M. (1971). Menstrual cycle of the baboon: I. clinical features, vaginal cytology and endometrial histology. Obstetrics and Gynecology, 38(3), 350.
Scopus19 Europe PMC101971 MaClennan, A. H., Harris, J. A., & Wynn, R. M. (1971). Menstrual cycle of the baboon: II. endometrial ultrastructure. Obstetrics and Gynecology, 38(3), 359.
Scopus16 Europe PMC141971 French, G. L., MacLennan, A. H., & Wynn, R. M. (1971). Nucleoside phosphatases in human amnion ultrastructural localization. Obstetrics and Gynecology, 37(2), 173-182.
Scopus3 Europe PMC31961 MACLENNAN, A. H. (1961). Fetal loss in cesarean section. American journal of obstetrics and gynecology, 82(1), 22-26.
Scopus1 Europe PMC2 -
Books
-
Book Chapters
-
Conference Papers
Year Citation 2022 van Eyk, C. L., Webber, D. L., Minoche, A., Perez-Jurado, L., Corbett, M., Gardner, A., . . . Gecz, J. (2022). Yield of clinically reportable genetic variants in cerebral palsy by whole genome sequencing. In EUROPEAN JOURNAL OF HUMAN GENETICS Vol. 30 (pp. 59). SPRINGERNATURE. 2010 O'Callaghan, M. E., MacLennan, A. H., Goldwater, P. N., McMichael, G., & et al. (2010). Australian Collaborative Study of genomic and environmental factors associated with CP. In Conference Proceedings. Sydney, Australia. 2010 McMichael, G. L., Gibson, C. S., MacLennan, A. H., & et al. (2010). Apolipoprotein E genotype is not associated with CP. In Developmental Medicine and Child Neurology. Sydney, Australia: Mac Keith Press. 2008 McMichael, G. L., Gibson, C. S., MacLennan, A. H., & et al.,. (2008). Stored cord serum: is it an additional resource for research into fetal viral exposure?. In Australian Society for Medical Research Conference, SA Branch. Adelaide, Australia. 2008 McMichael, G. L., Gibson, C. S., MacLennan, A. H., & et.al.,. (2008). Stored cord serum: is it an additional resource for research into fetal viral exposure?. In Perinatal Society of Australia and New Zealand 12th Annual Congress. Gold Coast, Australia. 2005 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2005). The association between inherited cytokine polymorphisms and cerebral palsy. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 193 (pp. S2). Miami Beach, FL: MOSBY, INC.
DOI2005 Gibson, C., Janssen, N., Kisi, W., MaClennan, A., Hague, B., Haan, E., . . . Dekker, G. (2005). The role of fetal inherited thrombophilia in the development of adverse pregnancy outcomes. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 193 (pp. S14). Miami Beach, FL: MOSBY, INC.
DOI2005 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2005). The role of fetal viral infection in the development of adverse pregnancy outcomes. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 193 (pp. S188). Miami Beach, FL: MOSBY, INC.
DOI2003 Gibson, C., Maclennan, A., Hague, B., Rudzki, Z., Sharpe, P., Chan, A., & Dekker, G. (2003). Fetal thrombophilic polymorphisms are not a risk factor for cerebral palsy. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 189 (pp. S75). NEW ORLEANS, LOUISIANA: MOSBY, INC.
DOI WoS32000 MacLennan, A. (2000). A template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement. International Cerebral Palsy Task Force.. In The Australian & New Zealand journal of obstetrics & gynaecology Vol. 40 (pp. 13-21). Australia: Wiley.
DOI Scopus16 Europe PMC91997 MacLennan, A. (1997). The general practitioner's perspective on the management of osteoporosis. In Australian Prescriber Vol. 20 (pp. 67-69). 1990 MACLENNAN, A. H. (1990). AUSTRALIAN CLINICAL-TRIALS WITH PROSTAGLANDIN-E2 AND PROSTAGLANDIN-F2-ALPHA TO INDUCE LABOR. In REPRODUCTION FERTILITY AND DEVELOPMENT Vol. 2 (pp. 557-561). MONASH MED CTR, MELBOURNE, AUSTRALIA: C S I R O PUBLICATIONS.
DOI WoS3 -
Conference Items
-
Original Creative Works
Year Citation 1994 Authors: MacLennan A. Title: Editorial. Description: N/A. Extent: N/A.
DOI -
Recorded/Rendered Creative Works
-
NHMRC Endorsed Guidelines
Year Citation 2007 Publication status: Published
Title: International Menopause Society Recommendations on Postmenopausal Hormone Therapy
Authors: MacLennan A
Author affiliation: A1000399
Pagination: 0 pages
Publication date: 2007
Language: en
Notes: Migrated record 20140814
Verification-status: Verified
Record created at source: 14 August 2014
Grants and Funding
Research Grants
2011-2013 |
Cerebral Palsy Institute/Foundation, NSW Special Initiative and infrastructure Grant |
600,000 |
2011-2014 | Australian Commonwealth “Health Workforce Australia” Grant for the establishment of a Women’s Health Teaching Clinic | 860,000 |
2012-2014 |
NHMRC Project Grant Copy Number Variations in Cerebral palsy |
640,000 |
2012-2013 |
Brain Foundation The contribution of inflammatory mediators to cerebral palsy |
39,000 |
2012-2013 |
Robinson Institute Research Grant The Genomics of Cerebral Palsy |
34,000 |
2014-2015 |
Research Foundation of Cerebral Palsy Alliance Defining the Role of genetic variations in cerebral palsy causation |
300,000 |
2014-2017 |
Research Foundation of Cerebral Palsy Alliance Tenix Adelaide cerebral palsy research group infrastructure grant |
800,000 |
2014 |
Rebecca L Cooper Medical Research Foundation Equipment Grant For data storage and analysis at Genetic Repositories Australia |
22,000 |
2016-2019 |
NHMRC Project Grant Genetic Pathways to Cerebral Palsy |
1302,000 |
2016 | School of Medicine Equipment Grant for an integrated Maxwell 16 Nucleic Acid Purification Platform | 30,000 |
2017-2018 |
Cerebral Palsy Foundation Research Grant Multi-omics investigations of cerebral palsy causation in discordant monozygotic twins and singletons. |
233,000 |
2018-2021 | Tenix Foundation Infrastructure Grant for the Australian Cerebral Palsy Research Group led by Professor MacLennan | 900,000 |
Teaching Experience
I have been a University Lecturer, Senior Lecturer, Reader or Associate Professor since 1973 and have been actively involved in undergraduate, postgraduate and midwifery teaching programmes. I have also been involved in the examination of these three groups of students. I have been a supervisor for PhD and MSc students, an external postgraduate examiner for Melbourne University, Sydney University, the Australian Medical Council, The Royal College of Midwives, Australian College of Physiotherapists and the Supervisor of Trainees for the Royal Australian College of Obstetricians and Gynaecologists. I enjoy teaching and am regularly involved in giving lectures by invitation to my peers at international and national College, Hospital and University meetings.
Educational Videos
I have been particularly involved in the development of video programmes for student and patient education. I have helped establish the Education Resource Centre at The Queen Victoria Hospital, Adelaide and have been involved in the production and direction of more than 35 video presentations for undergraduates, postgraduates, health personnel and the lay public. Some of these videos are now being distributed internationally (see list at end of publications).
On behalf of Adelaide University I have run 3 courses for gifted children entitled New Horizons in Reproductive Medicine.
In recent years I have been involved in changing our undergraduate curriculum from lecture-based to problem solving format with increasing clinical contact. I have helped develop new methods of student examination, including oral structured clinical examinations.
-
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2010 - 2012 Principal Supervisor The Genomics of Cerebal Palsy Are Copy Number Variants Associated with Cerebal Palsy? Master of Philosophy (Medical Science) Master Full Time Dr Gai McMichael 2010 - 2011 Principal Supervisor The Australian Cerebral Palsy Research Study ¿ Epidemiological & Genetic Associations with Cerebral Palsy Doctor of Philosophy Doctorate Full Time APrf Michael Edward O'Callaghan 2003 - 2005 Principal Supervisor Antenatal Causes of Cerebral Palsy and Adverse Pregnancy Outcomes: Investigating Associations between Inherited Thrombophilia, Cytokine Polymorphisms and Viral Infections Doctor of Philosophy Doctorate Full Time Dr Catherine Gibson
Connect With Me
External Profiles